1 RECEPTA biopharma Partnering for cancer drug development: Why in Brazil? Jose Fernando Perez CEO.
Predictive Analysis of Clinical Trials Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute .
University of Louisville “UofL shall be a premier metropolitan research university” -- HB1 (1997) A 10-year proven record of success: It is time to finish.
HOSA State Advisors Management Conference 9/24/14
UWM Research Report 2011
Cancer World 43
